Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Medtech Matters

Medtech Matters artwork

FDA Guidance on Off-Label Communication, Part 1

May 30, 202550 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re speaking about off-label communication. More specifically, we’re reviewing a recent guidance from the FDA that offers insights on how off-label communication can be performed in accordance to the regulation. We get a definition of the topic as well as examples of successful off-label communication efforts. During the discussion, the following questions are addressed: Can you first please provide an explanation of what “off-label” is in terms of the FDA? Before getting into the details of this “new” guidance, what is the difference between Off-Label Use vs. Off-Label Communication? What’s new in this “final” guidance? What is meant by firm-initiated communication containing scientific information on unapproved uses? If you communicate with an organization about unapproved (or off-label) uses, what will happen? If you send such a communication, are you acknowledging the off-label use and then need to submit it to FDA for a label expansion? Does FDA need to know about the communication? What else is important? What are the most important takeaways? Listen to this discussion and see if you can benefit from off-label communication. Then check out part 2 of this discussion. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com, and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode. Send us Fan Mail For more medtech news and information, visit https://www.mpomag.com.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. An Early Look at FDA’s Guidance Focus for 2027, Part 2

    Nov 2, 20261 hr 2 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re continuing the conversation of guidance documents that are expected to gain the attention of the agency...

    Credit the people on this episode

  2. An Early Look at FDA’s Guidance Focus for 2027, Part 1

    Nov 2, 202647 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we review the list of guidances FDA expects to begin to focus on in 2027. The list really represents the...

    Credit the people on this episode

  3. A Preview of MDUFA VI: Changes and Highlights, Part 2

    Sep 11, 202650 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re into part 2 of the discussion in an early look at the next Medical Device User Fee Act, MDUFA VI, which...

    Credit the people on this episode

  4. A Preview of MDUFA VI: Changes and Highlights, Part 1

    Sep 11, 202648 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re taking an early look at the next version of the Medical Device User Fee Act, MDUFA VI, which would go...

    Credit the people on this episode

  5. The Value in Partnering for Sterility Testing

    Sep 9, 202626 minAudio

    In this Medtech Matters podcast episode, sponsored by Nelson Labs, two representatives from the company offer their expertise and insights on sterility testing. Amina Rahmoune, Laboratory Operations Manager - Sterility...

    Credit the people on this episode